Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans
about
Systemic administration of local anesthetic agents to relieve neuropathic painSmall-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin.Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy.No association of polymorphisms in the serotonin transporter gene with thermal pain sensation in healthy individuals.Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury.Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty.Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review.Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems.A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models.A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults.Investigation of drug delivery by iontophoresis in a surgical wound utilizing microdialysis.Intradermal capsaicin causes dose-dependent pain, allodynia, and hyperalgesia in humans.Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of l-4-chlorokynurenine in healthy volunteers.
P2860
Q24245505-9212FD69-F253-4F02-8C8C-785F40D89522Q33247345-D9CD234B-CBE1-4918-8C0E-837612B8CDCBQ34809169-8E481DAC-455D-4CB0-9BD2-76F0A1C9075FQ35189456-55BBAA99-4931-4AE7-A0F4-728A3AC72FA6Q36860042-DC3D35BD-C090-400A-AD21-C0B05DEC1949Q36975271-EFFF89CB-AAFB-4821-BAE8-D9B43D4B9703Q37308436-D69E2596-EA5A-45CF-8E02-10D9A7D54A7AQ37397775-6F4F28F4-CF0F-408E-8A97-C0A7E30A826BQ38334849-D893A5F4-8E86-4D05-BB83-48FC98FF3113Q38839940-1837776B-6735-4661-B3E0-09FEA94BD1A8Q40057939-3D2A8D0C-D93C-4389-94FC-862D6EDD04C7Q43249580-798750E2-A45E-4635-85D3-024B71AF37A6Q46034935-CA00D389-C528-427D-9E71-DAB954560A00Q46242157-FACA838F-BC0A-4C16-935E-D7781717ADC4
P2860
Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Differential effects of system ...... ntradermal capsaicin in humans
@ast
Differential effects of system ...... ntradermal capsaicin in humans
@en
Differential effects of system ...... ntradermal capsaicin in humans
@nl
type
label
Differential effects of system ...... ntradermal capsaicin in humans
@ast
Differential effects of system ...... ntradermal capsaicin in humans
@en
Differential effects of system ...... ntradermal capsaicin in humans
@nl
prefLabel
Differential effects of system ...... ntradermal capsaicin in humans
@ast
Differential effects of system ...... ntradermal capsaicin in humans
@en
Differential effects of system ...... ntradermal capsaicin in humans
@nl
P2093
P1476
Differential effects of system ...... ntradermal capsaicin in humans
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.BJA.A013396
P407
P577
2000-02-01T00:00:00Z